TAKE LIMITED (NSE:TAKE)
20.83
-1.01 (-4.62%)
Aug 21, 2026, 3:29 PM IST
TAKE LIMITED Market Cap
TAKE LIMITED has a market cap or net worth of 3.08 billion as of August 21, 2026. Its market cap has increased by 91.06% in one year.
Market Cap
3.08B
Enterprise Value
3.08B
Revenue
845.59M
Ranking
n/a
PE Ratio
51.74
Stock Price
20.83
ChartMarket Cap Chart
Since August 27, 2007, TAKE LIMITED's market cap has decreased from 9.19B to 3.08B, a decrease of -66.45%. That is a compound annual growth rate of -5.59%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 3.08B | -47.24% |
| Dec 31, 2025 | 5.84B | 148.23% |
| Dec 31, 2024 | 2.35B | -30.20% |
| Dec 29, 2023 | 3.37B | -3.15% |
| Dec 30, 2022 | 3.48B | -51.33% |
| Dec 31, 2021 | 7.15B | -8.17% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.57T |
| Divi's Laboratories | 2.27T |
| Apollo Hospitals Enterprise | 1.26T |
| Cipla | 1.16T |
| Haleos Labs | 4.40B |
| Infinium Pharmachem | 3.43B |
| Nureca | 3.05B |
| Yash Optics & Lens | 2.71B |